These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 5018783)
1. [Activity of blood serum alkaline phosphatase in some surgical diseases of organs of the biliopancreatoduodenal system]. Galitskiĭ AB; Krylov LB; Kazinets ZF; Lipatova VA Khirurgiia (Mosk); 1972 Jan; 48(1):53-6. PubMed ID: 5018783 [No Abstract] [Full Text] [Related]
2. [Problems in the surgical treatment of cancer of the ampulla of Vater]. Vitebskiĭ IaD Vestn Khir Im I I Grek; 1972 Apr; 108(4):39-43. PubMed ID: 4116020 [No Abstract] [Full Text] [Related]
3. [Activity of blood serum alkaline phosphatase in surgical diseases of organs of the biliopancreatoduodenal system]. Galitskiĭ AB; Krylov LB; Kazinets ZF; Lipatova VA Khirurgiia (Sofiia); 1972; 25(1):53-6. PubMed ID: 5019619 [No Abstract] [Full Text] [Related]
4. [Selection of a method for treating cancer of the pancreaticoduodenal region]. Futorian ES; Shubin BM Vopr Onkol; 1971; 17(6):90-7. PubMed ID: 4109626 [No Abstract] [Full Text] [Related]
5. Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration. Erwald R; Hed R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL Diabetes; 1971 Oct; 20(10):686-90. PubMed ID: 5110700 [No Abstract] [Full Text] [Related]
6. [Blood coagulation factors in patients with obstructive jaundice]. Schneider M; Schulz K; Teichmann W Z Gesamte Inn Med; 1973 Jul; 28(13):403-7. PubMed ID: 4804904 [No Abstract] [Full Text] [Related]
7. [Clinical and laboratory criteria in the differential diagnosis of subhepatogenic jaundice]. Troitskiĭ KI Klin Med (Mosk); 1978 Feb; 56(2):33-8. PubMed ID: 633824 [No Abstract] [Full Text] [Related]
8. [Repeated operation in cancer of the pancreatic-duodenal zone]. Futorian ES; Zabaznyĭ NP Khirurgiia (Mosk); 1978 Nov; (11):73-9. PubMed ID: 723171 [No Abstract] [Full Text] [Related]
9. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study. Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581 [TBL] [Abstract][Full Text] [Related]
10. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy]. Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470 [TBL] [Abstract][Full Text] [Related]
11. CA 19.9 in biliopancreatic diseases. Lamiquiz Vallejo A; Dominguez Merru-Urrutia MJ; Loizate Totoricagüena A Int J Biol Markers; 1989; 4(1):51-2. PubMed ID: 2746047 [No Abstract] [Full Text] [Related]
12. Alkaline phosphatase activity in granulocytes of patients with cholecystitis and cholangitis, obstructive jaundice and neoplasms of the liver. Kusch F Pol Med J; 1971; 10(5):1102-11. PubMed ID: 5133659 [No Abstract] [Full Text] [Related]
13. Manifestations and prognosis of carcinoma of the liver. Malt RA; Van Vroonhoven TJ; Kakumoto Y Surg Gynecol Obstet; 1972 Sep; 135(3):361-4. PubMed ID: 4340970 [No Abstract] [Full Text] [Related]
14. [Indications, technic and immediate results of cephalic duodeno-pancreatectomy]. Hivet M; Richarme J; Chevrel JP J Chir (Paris); 1967 Nov; 94(5):403-16. PubMed ID: 5595304 [No Abstract] [Full Text] [Related]
15. [CLINICAL CONSIDERATION OF PANCREATIC CANCER]. OGURO C; AIDA M; MURONE I; NAGANUMA K; SATO Y; TSUKADA T; IMAI T; KUSAMA M; YAMADA K; SATO T; HIROSAWA M Sogo Rinsho; 1964 Mar; 13():498-507. PubMed ID: 14140838 [No Abstract] [Full Text] [Related]
16. [Functional results after duodenopancreatectomy (with special consideration of iron absorption, breath test, and serum gastrin) (author's transl)]. Maurer W; Kaufmann M; Kaess H; Voirol M; Borel GA; Duperrex U; Miller G Dtsch Med Wochenschr; 1974 Sep; 99(38):1863-6. PubMed ID: 4156006 [No Abstract] [Full Text] [Related]
17. [Surgical treatment of advanced cancer of the pancreas, liver, and biliary tract]. Liavåg I Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1295-7. PubMed ID: 1179339 [No Abstract] [Full Text] [Related]
18. [Pancreas penetration by ofloxacin--a pilot study]. Koch K; Drewelow B; Brinckmann W Z Gastroenterol; 1993 Oct; 31(10):587-91. PubMed ID: 8256472 [TBL] [Abstract][Full Text] [Related]
19. [Cancer of the liver, biliary tract and pancreas]. Sivula A; Lempinen M Duodecim; 1979; 95(12):779-87. PubMed ID: 520199 [No Abstract] [Full Text] [Related]
20. [Drainage of bile from the intrahepatic ducts in tumors localized in the porta hepatis]. Futorian ES; Shubin BM Vopr Onkol; 1967; 13(6):70-5. PubMed ID: 4175326 [No Abstract] [Full Text] [Related] [Next] [New Search]